Immunotherapy combination sets a new standard of care for extensive-stage small cell lung cancer

In patients with extensive-stage small cell lung cancer (ES-SCLC), tarlatamab, a bispecific T-cell engager, plus durvalumab as first-line maintenance therapy extended median overall survival by more than eight months, more…

Continue ReadingImmunotherapy combination sets a new standard of care for extensive-stage small cell lung cancer

New alpha-emitting radiopharmaceutical therapy achieves strong responses in advanced prostate cancer

A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting toxicities observed, and showed encouraging signs of antitumor activity, according to a phase 1…

Continue ReadingNew alpha-emitting radiopharmaceutical therapy achieves strong responses in advanced prostate cancer

The vaginal microbiome may relate to more than reproductive health

Researchers analyzed vaginal microbiota, metabolites, and psychological questionnaire scores in 105 young Italian women and found associations between microbial community types and reward responsiveness, motivational drive, and behavioral inhibition. Exploratory…

Continue ReadingThe vaginal microbiome may relate to more than reproductive health